# Oncopeptides AB (publ)

> Developing cancer therapies

Business model and tags: B2B, Has physical offices, Publicly traded, Manufacturing, Pharma & life sciences, Multi-site, International operations

## About Oncopeptides AB (publ)

Global biotech company developing therapies for hematological diseases using PDC platform to deliver cytotoxic agents into cancer cells Listed on Nasdaq Stockholm

## Key facts

- **Industry**: Pharmaceutical Manufacturing
- **Company size**: 51–250 employees
- **Headquarters**: Stockholm, Stockholm County, Sweden
- **Founded**: 2000
- **Revenue**: SEK 71.1M (FY2025, publicly reported)
- **Website**: [oncopeptides.com](https://oncopeptides.com/)
- **LinkedIn**: [linkedin.com/company/oncopeptides](https://www.linkedin.com/company/oncopeptides)

## Oncopeptides AB (publ) at a glance

Oncopeptides AB (publ) is a B2B company in the Pharmaceutical Manufacturing industry, headquartered in Stockholm, Stockholm County, Sweden.

Oncopeptides AB (publ) was founded in 2000.

Oncopeptides AB (publ) has 51–250 employees.

Oncopeptides AB (publ)'s revenue is SEK 71.1M (FY2025, publicly reported).

## Frequently asked questions about Oncopeptides AB (publ)

### What is Oncopeptides AB (publ)'s revenue?

Oncopeptides AB (publ)'s revenue is SEK 71.1M (FY2025, publicly reported).

### How many employees does Oncopeptides AB (publ) have?

Oncopeptides AB (publ) has 51–250 employees.

### Where is Oncopeptides AB (publ) headquartered?

Oncopeptides AB (publ) is headquartered in Stockholm, Stockholm County, Sweden.

---

Company data compiled by Tamtam from public sources and Tamtam's own analysis. Figures marked as estimates are modelled, not reported.

Source: https://www.tamtam.ai/c/oncopeptides-ab-publ